Static and dynamic effects of health policy: Evidence from the vaccine industry

Quarterly Journal of Economics

Volumn 119, Issue 2, 2004, Pages 527-564

  Finkelstein, Amy ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2542516942     PISSN: 00335533     EISSN: None     Source Type: Journal    
DOI: 10.1162/0033553041382166     Document Type: Article

References (37)

1. American Academy of Family Physicians, "Combination Vaccines for Childhood Immunizations, Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians," 2000. http://www.aafp.org/ clinical/chidimmun/combvacc.html
2. Bertrand, Marianne, Esther Duflo, and Sendhil Mullainathan, "How Much Should We Trust Differences-in-Differences Estimates?" Quarterly Journal of Economics, CXIX (2004), 249-276.
3. Center for Disease Control, "Using Live, Attenuated Influenza Vaccination for Prevention and Control of Influenza," Morbidity and Mortality Weekly Report, LII(RR13), 2003.
4. _, "National State and Urban Area Vaccination Coverage Levels among Children Aged 19-35 Months-United States," Morbidity and Mortality Weekly Report, 2002c, 2001, 1998, 1997, 1995a, various issues.
5. _, "Behavioral Risk Factor Surveillance System; Trend Data," http://198.246.97.130/brfss/Trends/trendchart.asp?qkey=10120&state=US, 2002b.
6. _, "Achievements in Public Health: Hepatitis B Vaccination-United States, 1982-2002," Morbidity and Mortality Weekly Report, LI (2002a).
7. _, "Influenza and Pneumococcal Vaccination Coverage Levels among Persons Aged Greater Than or Equal to 65 Years-United States, 1973-1993," Morbidity and Mortality Week Report, XLIV (1995b).
8. _, "Implementation of the Medicare Influenza Vaccination Benefit-United States, 1993," Morbidity and Mortality Weekly Report, XL (1994), 771-773.
9. _, "Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)," Morbidity and Mortality Weekly Report XL 40(RR-13), 1-19, July 22, 1991.
10. Cutler, David, and Elizabeth Richardson, "Your Money and your Life: The Value of Health and What Affects it," in Frontiers in Health Policy Research, Alan Garber, ed. (Cambridge, MA: MIT Press, 1999), pp. 99-132.
11. Decker, Michael, and Kathryn Edwards, "Combination Vaccines," in Plotkin and Orenstein, eds., Vaccines, 3rd edition (Philadelphia, PA: W.B. Saunders Company, 1999).
12. DiMasi, Joseph, Ronald Hansen, Henry Grabowski, and Louis Lasagna, "Cost of Innovation in the Pharmaceutical Industry," Journal of Health Economics, X (1991), 107-142.
13. Ellis, Ronald, "New Technologies for Making Vaccines," in Stanley Plotkin and Walter Orenstein, eds, Vaccines, 3rd edition. (Philadelphia, PA: W.B. Saunders Company, 1999).
14. Finkelstein, Arny, "Health Policy and Technological Change: Evidence from the Vaccine Industry." NBER Working Paper No. 9460, 2003.
15. General Accounting Office, "Vaccine Injury Compensation," GAO/HEHS-00-8, 1999.
16. Goolsbee, Austan, "Does Government R&D Policy Mainly Benefit Scientists and Engineers?" American Economic Review, LXXXVIII (1998), 298-302.
17. Health Resources and Services Administration, "Background information on VICP," 2002. http://www.hrsa.gov/osp/vicp/abdvic.htm
18. Hoyt, Kendall, "The Role of Military-Industrial Relations in the History of Vaccine Innovation," Ph.D. thesis, Massachusetts Institute of Technology, 2002.
19. Institute of Medicine, Vaccines for the 21st Century: A Tool for Decision Making (Washington, DC: National Academy Press, 2001).
20. _, New Vaccine Development: Establishing Priorities, Volume 1: Diseases of Importance in the United States (Washington, DC: National Academy Press, 1985a).
21. _, Vaccine Supply and Innovation (Washington, DC: National Academy Press, 1985b).
22. Kilburn, Edwin, and Nancy Arden, "Inactive Influenza Vaccines," in Stanley Plotkin and Walter Orenstein, eds., Vaccines, 3rd edition (Philadelphia, PA: W.B. Saunders Company, 1999).
23. Kitch, Edmund, Geoffrey Evans, and Robyn Gopin, "U.S. Law," in Plotkin and Orenstein, eds. Vaccines, 3rd edition (Philadelphia, PA: W.B. Saunders Company, 1999).
24. Kremer, Michael, "Creating Markets for New Vaccines-Part I: Rationale," in Jaffe, Lerner, and Stern, eds., Innovation Policy and the Economy (Cambridge, MA: MIT Press, 2001).
25. Mahoney, Francis, and Mark Kane, "Hepatitis B Vaccine," in Stanley Plotkin and Walter Orenstein, eds., Vaccines, 3rd edition (Philadelphia, PA: W.B. Saunders Company, 1999).
26. Mercer Management Consulting, Report on the United States Vaccine Industry (2000).
27. Merck, "Value of the 1999 Vaccine Market," presented to SMAG, July 20, 2000.
28. Newhouse, Joseph, "Medicare Care Costs: How Much Welfare Loss?" Journal of Economic Perspectives, VI (1992), 3-21.
29. NIH, "Understanding Vaccines," NIH Publication No. 98-4219, 1998.
30. Orenstein, W. A., and A. R. Himnan, "The Immunization System in the United States - The Eole of School Immunization Laws," Vaccine, XVII (1999), Supplement 3, S19-24.
31. PhRMA, Industry Profile 2000. http://www.phrma.org/publications/ publications/profile00/, 2000.
32. Schwartz, B., and W. A. Orenstein, "Vaccination Policies and Programs: the Federal Government's Role in Making the System Work," Primary Care, XXVIII (2001), 697-711.
33. Schmitz, R., D. Kidder, A. Schwartz, and P. Cook, "Final Results: Medicare Influenza Vaccine Demonstration-Selected States, 1988-1992," Morbidity and Mortality Weekly Review, XLII (1993), 601-604.
34. Schmookler, Jacob, Invention and Economic Growth (Cambridge, MA, Harvard University Press, 1966).
35. Struck, Mark M., "Vaccine R&D Success Rates and Development Times," Nature Biotechnology (1996), 591-593.
36. Weisbrod, Burton, "The Health Care Quadrilemma: An Essay on. Technological Change, Insurance, Quality of Care, and Cost Containment," Journal of Economic Literature, XXIX (1991), pp. 523-552.
37. Woodruff, B. A., J. Stevenson, H. Yusuf, S. L. Kwong, K. P. Todoroff, M. A. Hadler, and F. J. Mahoney, "Progress Toward Integrating Hepatitis B Vaccine into Routine Infant Immunization Schedules in the United States, 1991 through 1994," Pediatrics, XCVII (6 Pt 1); 798-803.